ArticleVaccine2018

Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus.

Seo-Yeon Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.